1st Circ. Rules Against Pfizer In 3 Neurontin RICO Suits

Law360, Los Angeles (April 3, 2013, 8:19 PM EDT) -- The First Circuit on Wednesday dealt Pfizer Inc. three major defeats over Neurontin litigation, ruling that the company's fraudulent marketing of the epilepsy drug directly caused Kaiser Foundation Health Plan Inc., Harden Manufacturing Corporation and Aetna Inc. to suffer financially.

The plaintiffs in all three cases alleged that Pfizer fraudulently marketed the anxiety disorder drug as having collateral, off-label benefits — and that the health care providers got stuck with having to pay for prescriptions that were actually ineffective at treating the conditions at issue....
To view the full article, register now.